Levels of soluble intercellular adhesion molecule-1 and total sialic acid in serum of patients with colorectal cancer

被引:23
作者
Basoglu, M [1 ]
Yildirgan, MI
Taysi, S
Yilmaz, I
Kiziltunc, A
Balik, AA
Celebi, F
Atamanalp, SS
机构
[1] Ataturk Univ, Sch Med, Dept Gen Surg, Erzurum, Turkey
[2] Ataturk Univ, Sch Med, Dept Biochem, Erzurum, Turkey
关键词
total sialic acid; soluble intercellular adhesion molecule-1; colorectal cancer;
D O I
10.1002/jso.10257
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: Serum soluble intercellular adhesion molecule-1 (sICAM-1) and total sialic acid (TSA) are related to the metastatic potential of cancer cells. The purpose of the present investigation was to determine sICAM-1 and TSA levels in colorectal carcinoma and correlate their levels with the cancer stage. Methods: The sera from 65 patients with colorectal cancer (18 at Dukes' 13, 24 at Dukes' C, 23 at Dukes' D) were extracted before treatment. The concentrations of sICAM-1 and TSA were measured by enzyme-linked immunoassay and the thiobarbituric acid method, respectively, and compared with those from a healthy control group (n = 42). Results: Mean serum sICAM-1 and TSA levels were found to be higher in the total patient group than in the control group (P < 0.0001). The concentrations of sICAM-1 and TSA were significantly higher in patients with Dukes' C and Dukes' D. The correlations between sICAM-1 and TSA became more significant as the stage of the disease increased (r = 0.58, P < 0.05 in Dukes' B, r = 0.88, P < 0.01 in Dukes' C and r = 0.81, P < 0.01 in Dukes' D). Conclusions: The results of this investigation indicate that sICAM-1 and TSA are the best of the tested markers. These markers should prove useful for monitoring malignant disease stage and for evaluating the effectiveness of various therapeutic approaches for colorectal carcinomas. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:180 / 184
页数:5
相关论文
共 27 条
  • [1] Levels of soluble intercellular adhesion molecule-1 and total sialic acid in serum of patients with laryngeal cancer
    Akcay, F
    Taysi, S
    Uslu, C
    Dogru, Y
    Gümüstekin, K
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (12) : 584 - 588
  • [3] CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1), E-SELECTIN AND VASCULAR CELL-ADHESION MOLECULE-1 (VCAM-1) IN HUMAN MALIGNANCIES
    BANKS, RE
    GEARING, AJH
    HEMINGWAY, IK
    NORFOLK, DR
    PERREN, TJ
    SELBY, PJ
    [J]. BRITISH JOURNAL OF CANCER, 1993, 68 (01) : 122 - 124
  • [4] BASOGLU M, 1988, TR J MED SCI, V28, P259
  • [5] EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1, CD54) IN COLONIC EPITHELIAL-CELLS
    DIPPOLD, W
    WITTIG, B
    SCHWAEBLE, W
    MAYET, W
    ZUMBUSCHENFELDE, KHM
    [J]. GUT, 1993, 34 (11) : 1593 - 1597
  • [6] ERBIL KM, 1985, CANCER, V55, P404, DOI 10.1002/1097-0142(19850115)55:2<404::AID-CNCR2820550219>3.0.CO
  • [7] 2-Q
  • [8] EXPRESSION AND MODULATION BY CYTOKINES OF THE INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IN HUMAN CENTRAL-NERVOUS-SYSTEM TUMOR-CELL CULTURES
    GUARINI, L
    TEMPONI, M
    BRUCE, JN
    BOLLON, AP
    DUIGOU, GJ
    MOULTON, TA
    FERRONE, S
    FISHER, PB
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (06) : 1041 - 1047
  • [9] HAKOMORI S, 1984, ANNU REV IMMUNOL, V2, P103, DOI 10.1146/annurev.immunol.2.1.103
  • [10] Serum cell adhesion molecules in patients with colorectal cancer
    Kitagawa, T
    Matsumoto, K
    Iriyama, K
    [J]. SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1998, 28 (03): : 262 - 267